Dermatan Sulfate
-
Subject Areas on Research
- "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
- A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke.
- A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
- Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
- Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
- Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy.
- Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
- Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
- Frequency, risk factors, anatomy, and course of unilateral neglect in an acute stroke cohort.
- Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.
- Large-dose infusions of heparinoid ORG 10172 in ischemic stroke.
- New treatment options for heparin-induced thrombocytopenia.
- Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
- Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
- Production of chemotactic peptides by neutrophil degradation of heparin cofactor II.
- Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
- Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
- Sugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds.
- The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening.
- The polarity and magnitude of ambient charge influences three-dimensional neurite extension from DRGs.
- The uveal effusion syndrome and trans-scleral flow.
-
Keywords of People
- O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology